- Advertisement -
Australian Clinical Labs (ASX: ACL) is set to nearly double its number of collection centres in NSW while solidifying its presence in QLD through the $70 million acquisition of Medlab Pathology.
After recently lifting its December half revenue guidance by around 30 per cent on the prospectus…

